Ines Gigler is a lab scientist in the research department at Boehringer Ingelheim in Biberach, Germany. From 2018-2025, she worked in cancer immunology and immune modulation. Currently, she works in cardiovascular research, where she conducts different experiments with iPSC-derived cardiomyocytes in 2D and 3D cell cultures. Gigler has bachelor's and master's degrees in molecular medicine from the University of Würzburg and the University of Ulm, respectively.